GPR12 Activators are a class of compounds that interact with or influence the signaling pathways of the G protein-coupled receptor GPR12. These activators can enhance the receptor's activity by engaging with the complex network of intracellular signaling cascades that GPR12 is part of. Sphingosine-1-phosphate (S1P), for instance, is a lipid signaling molecule that binds to GPR12, leading to the activation of downstream signaling pathways involving calcium mobilization and inhibition of adenylyl cyclase. This interaction enhances GPR12's ability to respond to external stimuli and propagate cellular responses. Similarly, lysophosphatidic acid (LPA) stimulates GPR12 by activating G proteins, which in turn initiate a series of intracellular events such as the activation of phospholipase C. This leads to the generation of diacylglycerol and inositol trisphosphate, second messengers that further modulate cellular functions associated with GPR12.
Other compounds like anandamide and 2-Arachidonoylglycerol (2-AG) are part of the endocannabinoid system and act on G protein-coupled receptors like GPR12 to trigger signaling mechanisms that enhance the receptor's activity. Anandamide's binding to GPR12 can facilitate the activation of the PI3K/AKT pathway, which is crucial for several cellular processes. On the other hand, 2-AG can inhibit adenylyl cyclase and activate MAPK, which are key pathways in GPR12 signaling. Adenosine and uridine diphosphate (UDP) are purines that interact with their respective G protein-coupled receptors, and through signaling cross-talk, they can enhance the function of GPR12. Additionally, compounds like FTY720 and VPC 23019 modulate sphingosine 1-phosphate receptors, affecting GPR12 indirectly by influencing the sphingosine-related pathways, which are integral to GPR12's role in cellular signaling. Cannabidiol (CBD) and CP-55,940 modulate the endocannabinoid system, which shares signaling pathways with GPR12, and their interactions can lead to an enhanced functional activity of GPR12. Lastly, capsaicin, by binding to the vanilloid receptor, influences GPR12 activity through downstream effectors such as calcium ions and protein kinase C (PKC), highlighting the diverse yet specific ways in which these compounds can enhance the functionality of GPR12.
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
ジブチルリルcAMPは、細胞内cAMPレベルを増加させ、プロテインキナーゼA(PKA)やその他の下流のシグナル伝達事象を含むcAMP依存経路の活性化につながる環状AMP(cAMP)の類似体です。これらの経路は、間接的にGPCRシグナル伝達に影響を与える可能性があります。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMAはプロテインキナーゼC(PKC)の強力な活性化因子であり、様々な細胞内シグナル伝達経路を調節することができる。PKCの活性化は、間接的にGPCRシグナル伝達に影響を与える可能性がある。 | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $336.00 $1642.00 | 20 | |
カルホスチンCはPKCの阻害剤であり、GPCRシグナル伝達と交差する下流のシグナル伝達経路に影響を及ぼす可能性がある。 | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
ロリプラムはホスホジエステラーゼ4(PDE4)を選択的に阻害し、cAMPレベルを上昇させ、cAMP依存性経路を活性化し、間接的にGPCRシグナル伝達に影響を与える。 | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $102.00 $347.00 | 7 | |
8-Br-cGMPは環状GMP(cGMP)の類似体であり、cGMPによって制御される細胞プロセスに影響を与え、GPCRを介する経路と交差する可能性がある。 | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmanninはホスホイノシチド3キナーゼ(PI3K)の阻害剤であり、GPCRシグナル伝達経路と交差する可能性のあるPI3K/Aktシグナル伝達経路のキープレイヤーである。 | ||||||